Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 pharmaceuticals ranked by net assets, at AED 317.6B, ahead of Johnson & Johnson (AED 299.5B) and Sanofi (AED 290.8B). Figures as of 18 Nov 2026, 14:39 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerAED 317.6B
- Median
- AED 3.2B
- Combined market value
- AED 18.9T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | AED 317.6B | AED 595.9B | AED 104.54 | 0.02% up | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | AED 299.5B | AED 2.46T | AED 1,022.38 | 0.16% down | 38% up | ||
| 3 | SanofiSNY · Health Care | AED 290.8B | AED 419.3B | AED 174.63 | 0.04% up | 4% down | ||
| 4 | Merck & CoMRK · Health Care | AED 193.2B | AED 1.27T | AED 516.40 | 1.95% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | AED 191.5B | AED 666B | AED 384.54 | 0.05% down | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | AED 178.7B | AED 1.03T | AED 664.28 | 0.74% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | AED 170.9B | AED 252.6B | AED 79.05 | 0.55% down | 54% up | ||
| 8 | NovartisNVS · Health Care | AED 169.4B | AED 1.09T | AED 578.65 | 1.01% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | AED 114.8B | AED 366.6B | AED 3,543.58 | 0.74% up | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | AED 105.8B | AED 653.2B | AED 148.21 | 0.86% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | AED 97.5B | AED 4.63T | AED 5,203.41 | 0.10% up | 35% up | ||
| 12 | GSKGSK · Health Care | AED 79.8B | AED 362.3B | AED 180.77 | 0.01% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | AED 68.6B | AED 498.5B | AED 1,966.31 | 0.22% up | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | AED 67.8B | AED 457.4B | AED 223.77 | 0.73% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | AED 54B | AED 86.7B | AED 75.64 | 0.71% up | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | AED 35.7B | AED 145.4B | AED 252.82 | 0.23% up | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | AED 29.1B | AED 183.4B | AED 157.22 | 0.47% up | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | AED 26.1B | AED 91.4B | AED 2,145.73 | 0.03% up | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | AED 24B | AED 48.5B | AED 96.99 | 2.17% up | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | AED 22.4B | AED 42B | AED 216.61 | 0.80% up | 11% up | ||
| 21 | GrifolsGRFS · Health Care | AED 21.5B | AED 21.6B | AED 31.69 | 0.00% | 1% up | ||
| 22 | GenmabGMAB · Health Care | AED 21.5B | AED 117.6B | AED 190.72 | 0.06% down | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | AED 16.6B | AED 103.4B | AED 142.71 | 0.38% up | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | AED 16B | AED 171.9B | AED 1,504.52 | 0.87% down | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | AED 15.9B | AED 56.6B | AED 882.47 | 0.18% down | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | AED 14.7B | AED 45.7B | AED 54.87 | 0.95% up | 5% up | ||
| 27 | ZoetisZTS · Health Care | AED 12.2B | AED 125.5B | AED 308.76 | 0.71% up | 29% down | ||
| 28 | AlkermesALKS · Health Care | AED 6.7B | AED 28.5B | AED 169.66 | 1.64% up | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | AED 3.7B | AED 21.8B | AED 1,091.75 | 1.18% up | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | AED 3.7B | AED 12B | AED 61.66 | 4.22% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | AED 3.2B | AED 31.3B | AED 1,120.99 | 0.06% up | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | AED 2.9B | AED 76.9B | AED 574.43 | 0.06% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | AED 2.8B | AED 23.5B | AED 579.24 | 0.00% | 31% up | ||
| 34 | InsmedINSM · Health Care | AED 2.7B | AED 98.4B | AED 448.35 | 0.18% up | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | AED 2.6B | AED 33.1B | AED 348.51 | 1.16% up | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | AED 2.4B | AED 31B | AED 38.76 | 1.08% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | AED 2.4B | AED 35.2B | AED 233.11 | 1.22% up | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | AED 2.4B | AED 28.4B | AED 259.49 | 0.83% up | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | AED 2.3B | AED 18.1B | AED 103.90 | 1.58% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | AED 2.3B | AED 30.2B | AED 462.56 | 1.03% up | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | AED 2.2B | AED 35.9B | AED 1,544.25 | 0.36% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | AED 2.1B | AED 27.8B | AED 353.84 | 1.30% up | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | AED 1.9B | AED 17B | AED 155.11 | 0.46% up | 88% up | ||
| 44 | ABIVAXABVX · Health Care | AED 1.9B | AED 26.7B | AED 305.41 | 1.29% up | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | AED 1.8B | AED 18.1B | AED 320.58 | 0.36% up | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | AED 1.8B | AED 16.8B | AED 101.00 | 2.00% up | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | AED 1.7B | AED 24.6B | AED 362.65 | 2.52% up | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | AED 1.7B | AED 22.4B | AED 158.23 | 0.22% up | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | AED 1.2B | AED 14.8B | AED 108.23 | 0.31% up | 169% up | ||
| 50 | ErascaERAS · Health Care | AED 1.2B | AED 17.8B | AED 50.72 | 0.58% down | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | AED 1.2B | AED 21.9B | AED 336.15 | 0.46% down | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | AED 510.7M | AED 29.5B | AED 425.69 | 0.60% down | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | AED 421.7M | AED 18B | AED 187.23 | 0.23% down | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | AED 324.3M | AED 26.4B | AED 501.75 | 0.49% up | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -AED 260M | AED 27.4B | AED 78.62 | 1.36% up | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -AED 444.4M | AED 19.6B | AED 464.46 | 0.46% up | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -AED 663.5M | AED 65.3B | AED 995.42 | 0.06% down | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -AED 754M | AED 18.5B | AED 221.18 | 0.22% down | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -AED 2.4B | AED 26.6B | AED 191.18 | 0.78% up | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -AED 7.7B | AED 55.1B | AED 282.86 | 0.29% up | 17% up | ||
| 61 | AbbVieABBV · Health Care | -AED 12B | AED 1.89T | AED 1,071.04 | 0.42% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6726 AED).
Questions and answers
Which pharmaceuticals rank first by net assets?
Pfizer (AED 317.6B), Johnson & Johnson (AED 299.5B) and Sanofi (AED 290.8B) are the top three of the 61 pharmaceuticals ranked by net assets as of 18 Nov 2026, 14:39 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of AED 18.9T as of 18 Nov 2026, 14:39 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.